NCT01038752 Evaluation of Non-cytotoxic Suramin as a Chemosensitizer in Non-small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT01038271 Integrated Versus Standard Palliative Care in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Status COMPLETED Phase NA
NCT01028612 Thermal Ablation Combined With External Beam Radiation Therapy for Patients With Inoperable Non-Small Cell Lung Cancer > 3.5 cm in Size Status TERMINATED Phase NA
NCT01026844 Hydroxychloroquine With or Without Erlotinib in Advanced Non-small Cell Lung Cancer (NSCLC) Status TERMINATED Phase PHASE1
NCT01024062 Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT01023828 K-RAS Oncogene Mutation in Patients With Advanced Non-Small Cell Lung Cancer Associated With Exposure to Wood Smoke and Tobacco Smoking: Therapeutic Implications Status COMPLETED Phase N/A
NCT01017679 Gefitinib 500mg Versus 250mg in Patients With NSCLC With Stable Disease After a Month Treatment of Gefitinib 250mg Status COMPLETED Phase PHASE2
NCT01017133 Fluorine F18-EF5 and Fludeoxyglucose F18 Positron Emission Tomography in Assessing Hypoxia and Glycolysis in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT01015443 Cancer Vaccine Study for Stage III, Unresectable, Non-small Cell Lung Cancer (NSCLC) in the Asian Population Status TERMINATED Phase PHASE3
NCT01011075 Study of Gleevec and Weekly Paclitaxel in Patients Aged 70 or Older With Advanced Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT01004250 A Study of Pemetrexed and Bevacizumab for Participants With Advanced Non-Small Cell Cancer Status COMPLETED Phase PHASE2
NCT01003522 Evaluation of Stents to Open Restricted Airways in Patients With Centrally Placed Non-small Cell Lung Cancer Status UNKNOWN Phase PHASE3
NCT01000740 A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa Status COMPLETED Phase PHASE4
NCT00998166 A Study of Cisplatin + Pemetrexed + Avastin as First-Line Therapy Status TERMINATED Phase PHASE2
NCT00997724 Assisted-VATS Sleeve Lobectomy for Non-small Cell Lung Cancer Status UNKNOWN Phase PHASE2
NCT00997334 Erlotinib Therapy and Subsequent Development of Mechanisms of Secondary Resistance in Patients With NSCLC Status COMPLETED Phase PHASE2
NCT00995761 Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT00994097 NGR-hTNF in Combination With Standard Chemotherapy to Treat Patients With Advanced Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00991796 CS-1008 With Carboplatin/Paclitaxel in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT00985998 Nimotuzumab in Combination With Cisplatin and Docetaxel for Patients With Advanced Non-small Cell Lung Cancer Status WITHDRAWN Phase PHASE1